TCTR20211223006已完成1 期
Evaluating the efficacies of the hair growing stimulation and hair losing reduction products: ardermis Youth Factor extra strength Hair Formula (sh-Oligopeptide-1) and ardermis Youth Factor extra strength Hair Formula XL (sh-Oligopeptide-1)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 98
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Years 至 55 Years(—)
- 性别
- Male
入选标准
- •1. Healthy male volunteers with baldness of the 2nd to 4th degree (Type II - IV), according to the Hamilton-Norwood classification.
- •2. Age between 20-55 years old.
- •3. No serious congenital diseases such as asthma, high blood pressure, heart disease, etc.
- •4. The blood pressure is not lower than 90/60 and not higher than 140/90.
- •5. No history of allergy to ingredients in hair care products or allergic to Minoxidil.
- •6. Volunteers voluntarily participate in the project after being informed of the objectives, methods and risks of the study and agree to follow the guidelines for participating in the project for a period of 6 months before starting the trial. All volunteers must sign a voluntary consent form.
排除标准
- •1. Have a history of allergic reactions or abrasions on the scalp
- •2. During the 6 months prior to participating in the research project, the volunteer uses hair products that contain Minoxidil.
- •3. Get treatment for baldness with products containing 5alpha-reductase inhibitors or isotretinoin, or receiving chemotherapy or radiotherapy during the 1 year prior to participating in the research project
- •4. Have used natural hair care products that have contributed to hair regrowth in the past 3 months.
- •5. Have used steroid products on the scalp continually for a period of 14 days in the 3 months prior to participation in the study
- •6. Have a congenital disease such as high blood pressure or heart disease
- •7. History of using drug that affects blood pressure.
研究者
相似试验
已完成
不适用
Efficacy Confirmation Test of Hair Growth and Nurturing Composition (HGT) in Continuous Usethinning hairJPRN-UMIN000044574ROHTO Pharmaceutical Co., Ltd.67
Enrolling By Invitation
2 期
Efficacy and safety of a hair growth promoting product containing topical 1% melatonin for treatment of androgenetic alopecia in women: A randomized double-blind trialFemale pattern hair loss (Androgenetic alopecia)TCTR20201227001Faculty of Medicine, Thammasat University (Rungsit campus)100
已完成
不适用
Evaluation of hair growth effects by application of hair lotion containing lactic-acid bacteriaHealthy adultsJPRN-UMIN000044792Shiba Palace Clinic110
已完成
不适用
Evaluation of hair growth effect by combined use of medicated hair-growth tonic and massageHealthy adultJPRN-UMIN000042672Japan Clinical Trial Association21
已完成
Unknown
The effectiveness and safety evaluation of hair growth promotor containing teak leaf extractISRCTN24541842ational Research Council of Thailand90
